Chemfab Alkalis (Small Cap - Potential Multibagger) Share Target 2026, 2027 To 2035
|
Chemfab Alkalis Limited |
|||
|
Price: ₹384.90 (-1.7%) | ||
| 52 Week Low: ₹290.35 52 Week High: ₹849.60 |
|||
| Market Capital: 565.6 Crore (Small-cap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Chemfab Alkalis Share Price Target For 2026
- 1.1.1: Chemfab Alkalis Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Chemfab Alkalis Share Price Target For 2027
- 1.2.1: Chemfab Alkalis Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Chemfab Alkalis Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Chemfab Alkalis Brief Company Overview
- 4: Chemfab Alkalis Financial Performance
- 4.0.1: Is Chemfab Alkalis A Good Buy For Long Term?
Chemfab Alkalis, a Small Cap company in the Specialty Chemicals Industry has delivered 165.5% returns in 5-year showing 2.9% quarterly revenue growth with 3.9% profit margin, making it a potential Multibagger.
To predict the Chemfab Alkalis's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Chemfab Alkalis Share Price Target For 2026
The line chart displays the monthly closing prices of Chemfab Alkalis with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Chemfab Alkalis shares in 2026, see the table below.
Chemfab Alkalis Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 422.53 (+9.77%) | Volatility: BB Upper |
| 2026 Target 2 | 400.97 (+4.17%) | Trend: SMA50 |
| 2026 Target 1 | 397.67 (+3.31%) | Trend: EMA9 |
| Current Price | 384.90 | Chemfab Alkalis's share price as of 15 Jun 2026 |
| Stop Loss 1 | 327.21 (-14.99%) | Volatility: ATR S1 |
| Stop Loss 2 | 298.18 (-22.54%) | 98.60% Weekly Fib Retrace |
| Stop Loss 3 | 288.75 (-24.99%) | Volatility: ATR S2 |
Short-Term Technical Outlook
Current Technical Position: Chemfab Alkalis is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹369.32 serves as the nearest technical reference point.
Historical Returns: 3-month: +8.7% | 6-month: -17.14% | 1-year: -48.49%
Chemfab Alkalis Share Price Target For 2027
The line chart displays the monthly closing prices of Chemfab Alkalis with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Chemfab Alkalis shares in 2027, see the table below.
Chemfab Alkalis Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 422.53 (+9.77%) | Volatility: BB Upper |
| 2027 Target 2 | 400.97 (+4.17%) | Trend: SMA50 |
| 2027 Target 1 | 397.67 (+3.31%) | Trend: EMA9 |
| Current Price | 384.90 | Chemfab Alkalis's share price as of 15 Jun 2026 |
| Stop Loss 1 | 327.21 (-14.99%) | Volatility: ATR S1 |
| Stop Loss 2 | 298.18 (-22.54%) | 98.60% Weekly Fib Retrace |
| Stop Loss 3 | 288.75 (-24.99%) | Volatility: ATR S2 |
Long-Term Technical Outlook
52-Week Range Analysis: Chemfab Alkalis is currently trading near its 52-week low of ₹290.35, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -48.49% | 3-year: +20.11% | 5-year: +165.46%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Chemfab Alkalis Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹384.90 | ||
| 2026 | ₹509.21 | +32.296700441673% | ₹516.85 |
| 2027 | ₹666.83 | +30.953830443236% | ₹676.83 |
| 2028 | ₹807.53 | +21.099830541517% | ₹819.64 |
| 2029 | ₹1,028.56 | +27.37111933922% | ₹1,043.99 |
| 2030 | ₹1,336.93 | +29.980749786109% | ₹1,356.98 |
| 2031 | ₹1,614.97 | +20.796900361275% | ₹1,639.19 |
| 2032 | ₹2,025.14 | +25.397995009195% | ₹2,055.52 |
| 2033 | ₹2,486.91 | +22.801880363827% | ₹2,524.21 |
| 2034 | ₹2,773.67 | +11.530775138626% | ₹2,815.28 |
| 2035 | ₹3,322.06 | +19.77127776556% | ₹3,371.89 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Chemfab Alkalis Brief Company Overview
Chemfab Alkalis Limited: A Chemical Giant in India Chemfab Alkalis Limited, founded in 1985, is a prominent manufacturer and distributor of inorganic chemicals in India and globally. The Chennai-based company has established a solid reputation in the industry for its...
extensive product range. Chemfab Alkalis categorizes its products into two segments: Chemicals and Related Products/Services and PVC-O Pipes. The company's diverse offerings include caustic soda, chlorine, hydrochloric acid, salt, hydrogen gas, and bleach liquor, catering to various industrial and commercial applications. Committed to innovation, Chemfab Alkalis continues to expand its product portfolio, meeting the evolving needs of its customers. The company's unwavering commitment to quality has garnered industry recognition and trust among its clients.Chemfab Alkalis Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,381.65 Crore | Market valuation of Chemfab Alkalis's shares. |
| Revenue (TTM) | 327.06 Crore | Total revenue generated by Chemfab Alkalis over the past twelve months. |
| Net Income (TTM) | +12.87 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 1.64% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 3.93% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+2.9% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
20.96 | Company's total debt divided by total shareholder equity. |
| Total Debt | 81 Crore | Sum of Chemfab Alkalis's current & long-term financial obligations. |
| Total Cash | 2.79 Crore | Total amount of liquid funds available to Chemfab Alkalis. |
| Beta | 0.16 | Beta is less than 1 indicating that the Chemfab Alkalis's price is less volatile than the market. |
Is Chemfab Alkalis A Good Buy For Long Term?
Chemfab Alkalis, a small-cap stock with a market capitalization of ₹1,381.65 crore, shows significant growth potential but also carries considerable risk. While its 12-month revenue reached ₹327.06 crore and YTD returns are impressive at 151.43%, a low net profit margin of 3.93% and a debt of ₹81 crore against a cash balance of only ₹2.79 crore raise concerns. The substantial past performance (5-year return: 480.69%) doesn't guarantee future success. Therefore, it's an average buy for long-term investors with a high-risk tolerance. Further due diligence is strongly recommended.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
